13.07.2015 Views

Development of hot-melt extrusion as a novel technique for the ...

Development of hot-melt extrusion as a novel technique for the ...

Development of hot-melt extrusion as a novel technique for the ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

8.0 ConclusionsThe presence <strong>of</strong> intermolecular interactions h<strong>as</strong> successfully led <strong>the</strong> HME to be arobust <strong>technique</strong> to <strong>for</strong>m solid dispersions <strong>of</strong> both APIs into polymer matrix. The existence <strong>of</strong>amorphous APIs into <strong>the</strong> polymer matrices h<strong>as</strong> been confirmed by <strong>the</strong>rmal analysis while anin vivo and in vitro t<strong>as</strong>te m<strong>as</strong>king analysis h<strong>as</strong> substantially complemented each o<strong>the</strong>rshowing <strong>the</strong> m<strong>as</strong>king potential <strong>of</strong> L100 better than L100-55. The molecular modellingoutlined a possible presence <strong>of</strong> intermolecular interactions between drug and polymermolecules and estimated <strong>the</strong> strength. The findings from FT-IR and XPS analysis h<strong>as</strong> finallyconfirmed <strong>the</strong> mechanism <strong>of</strong> <strong>the</strong> interaction through H-bonding between <strong>the</strong> carboxyl group<strong>of</strong> <strong>the</strong> anionic methacrylate co-polymer and <strong>the</strong> amide group <strong>of</strong> <strong>the</strong> active substances <strong>as</strong> well<strong>as</strong> <strong>the</strong> interaction strength. These studies finally confirm that <strong>the</strong> stronger <strong>the</strong> integrationsbetter <strong>the</strong> t<strong>as</strong>te m<strong>as</strong>king in an opposite charged drug/polymers b<strong>as</strong>ed extruded soliddispersions.9.0 References1. Douroumis DD, Gryczke A, Schminke S. <strong>Development</strong> and evaluation <strong>of</strong> cetirizineHCl t<strong>as</strong>te-m<strong>as</strong>ked oral disintegrating tablets. AAPS PharmSciTech. 2011; 12: 141–151.2. Maniruzzaman M, Boateng JS, Bonnefille M, Aranyos A, Mitchell JC, Douroumis D.T<strong>as</strong>te m<strong>as</strong>king <strong>of</strong> paracetamol by <strong>hot</strong>-<strong>melt</strong> <strong>extrusion</strong>: an in vitro and in vivoevaluation. Eur. J Pharm. Biopharm. 2012; 80(2): 433-42.3. Ayenew Z, Puri V, Kumar L, Bansal AK. Trends in pharmaceutical t<strong>as</strong>te m<strong>as</strong>kingtechnologies: a patent review. Recent Pat. Drug Deliv. Formul.2009; 3: 26–39.4. Bora D, Borude P, Bhise K. T<strong>as</strong>te m<strong>as</strong>king by spray-drying <strong>technique</strong>. AAPSPharmSciTech. 2008; 9: 1159–1164.5. Al-Omran MF, Al-Suwayeh SA, El-Helw AM, Saleh SI. T<strong>as</strong>te m<strong>as</strong>king <strong>of</strong> dicl<strong>of</strong>enacsodium using microencapsulation. J Microencapsul. 2002; 19:45–52.6. Shah PP, M<strong>as</strong>hru RC, Rane YM, Thakkar A. Design and optimization <strong>of</strong> mefloquinehydrochloride microparticles <strong>for</strong> bitter t<strong>as</strong>te m<strong>as</strong>king. AAPS PharmSciTech. 2008;9:377–389.7. Albertini B, Cavallari C, P<strong>as</strong>serini N, Voinovich D, González-Rodríguez ML,Magarotto L, Rodriguez L. Characterization and t<strong>as</strong>te-m<strong>as</strong>king evaluation <strong>of</strong>147 | P a g e

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!